Description
+ Include: 4 videos + 19 pdfs, size: 7.4 GB
+ Target Audience: addiction therapist
+ Sample video: contact me for sample video
+ Information:
April 17 – 18, 2025
The 5th Annual UCSF Addiction CME Conference aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care. This is a Virtual Conference.
Target Audience
Physicians
Nurse practitioners and Physician Associates (PAs)
Topics Covered
- Keynote address from a person with lived experience of Substance Use Disorder (SUD)
- SUD as a brain disease, stigma
- Opioid Use Disorder, including starting buprenorphine and methadone
- Alcohol use disorder
- Benzodiazepine use disorder and withdrawal management
- Stimulant use disorder
- Pregnancy and SUDs
- Pain and SUDs
- Hospital based care for patients with SUDs
- Communication and documentation in caring for patients with SUDs
Objectives
Attendees completing this course will be able to:
- Apply new knowledge in practice to more often recognize signs of substance use disorders (SUDs)
- Implement screening in practice to confirm SU
- Consider a broader set and combination of evidence-based treatments for opioid, alcohol, and stimulant use disorders in management of SU
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
10_Dianna Coffa – Communication with Patients.pdf
11_Tauheed Zaman – Benzodiazepine.pdf
12_Alex Logan – Hospital Based Care.pdf
13_Hannah Snyder – Telehealth and Patient Centered Documentation.pdf
14 _Case 2- AUD, Stim UD, Benzo UD_FACILITATOR (1).docx
14 _Case 2- AUD, Stim UD, Benzo UD_PARTICIPANT.docx
15_Jesse Ristau – Rapid Review of Case 2.pdf
16_Mishka Terplan – Pregnancy and SUD.pdf
17_Elizabeth Abbs – Controlled Medication Management.pdf
2_Johanna Sluser – Stigma and Clinical Diagnosis of SUD.pdf
3_VERSION 2_Khaled Moussawi_SUD as a Brain Disease.pdf
4 _Andy Tompkins – OUD Diagnosis and Methadone Induction.pdf
5_Christy Soran – Complex Buprenorphine Inductions.pdf
6_Case 1- OUD_FACILITATOR (1).docx
6_Case 1- OUD_PARTICIPANT.docx
7_ Jesse Ristau – Rapid Review of Case 1.pdf
8_ Ayesha Appa – Stimulant Use Disorder Treatment.pdf
9_ Triveni Defries – Alcohol Use Disorder.pdf
April 17 AM.mp4
April 17 PM.mp4
April 18 AM.mp4
April 18 PM.mp4
Syllabus Introduction_MDM25P05.pdf
* Detail:
| Day 1: April 17, 2025 | |||
| 8:00am – 8:15am | Welcome from the Conference Co-Chairs: Jesse Ristau*, MD and Alex Logan*, MD | ||
| 8:15am -8:55am | Jose P, Drug and Alcohol Counselor | Drug Treatment Program | Keynote Address |
| 8:55am – 9:25am | Johanna Sluser*, FNP-C, CARN-AP | Hospital medicine, Psychiatry | Stigma and clinical diagnosis of SUD |
| 9:25am -9:55am | Khaled Moussawi, MD, PhD – University of California San Francisco | Neurology | SUD as a brain disease |
| Break – 15 mins | |||
| 10:10am -11:10am | Andy Tompkins*, MD | Psychiatry, OTP | OUD diagnosis and methadone induction |
| 11:10am -12:10pm | Christy Soran*, MD, MPH | Primary Care, OBIC | Complex Buprenorphine Inductions |
| Lunch Break – 12:10pm – 1:40pm | |||
| 1:40pm -2:20pm | Small Groups | Case 1: OUD diagnosis and treatment | |
| 2:20pm -2:35pm | Jesse Ristau*, MD | Primary Care, Inpatient Consult | Rapid review of Case 1 Clinical Pearls |
| Break – 15 mins | |||
| 2:50pm -3:50pm | Ayesha Appa*, MD | Internal Medicine | Stimulants, drug involved deaths |
| 3:50pm -4:50pm | Triveni Defries*, MD | Internal Medicine | Alcohol Use Disorder: Diagnosis and Treatment |
| 4:50pm -5:00pm | Closing | ||
| Day 2: April 18, 2025 | |||
| 8:00am -8:15am | Introductions: Jesse Ristau*, MD and Alex Logan*, MD | ||
| 8:15am -8:55am | Dianna Coffa*, MD | Family & Community Medicine, ZSFG | Communication with patients who use substances |
| 8:55am -9:55am | Tauheed Zaman*, MD | Psychiatry, SFVA | Benzodiazepine Use disorder and detoxification |
| Break – 15 mins | |||
| 10:10am -11:10am | Alex Logan*, MD | Hospital Medicine | Hospital based care for patients with SUD including Opioid Withdrawal Management |
| 11:10am-12:10pm | Hannah Snyder*, MD | Family & Community Medicine, ZSFG | Telehealth and Patient Centered Documentation |
| Lunch Break – 12:10pm – 1:40pm | |||
| 1:40pm -2:20pm | Small Groups | Case 2: Complex care inpt, outpt, multiple substances, utox (includes 5min of transition time) | |
| 2:20pm -2:35pm | Jessica Ristau*, MD | Primary care and Inpatient consult | Rapid Review of Case 2 Clinical Pearls |
| Break – 15 mins | |||
| 2:50pm -3:50pm | Mishka Terplan*, MD | OB/GYN | Pregnancy and SUD |
| 3:50pm -4:50pm | Elizabeth Abbs*, MD | Internal Medicine | Controlled medication management and SUD |
| 4:50pm -5:00pm | Closing | ||
Reviews
There are no reviews yet.